Editas Medicine, Inc.
7 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Mar 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 6 to 20, 2026 · next Dec 6
- 1 fee due Apr 1, 2027The maintenance fee for Engineered CAS9 Nucleases (US 10,428,319) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due May 7, 2027The maintenance fee for Methods and Compositions for Treating Cone-Rod Retinal Dystrophy (US 11,806,408) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
- 3 fees due Jun 3 to 26, 2027 · next Jun 3
- 1 fee due Jul 9, 2027The maintenance fee for Systems and Methods for Targeted Integration and Genome Editing and Detection Thereof Using Integrated Priming Sites (US 11,866,726) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 1 fee due Aug 27, 2027The maintenance fee for CRISPR/Cas-Related Methods and Compositions for Improving Transplantation (US 11,911,415) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for CRISPR/RNA-Guided Nuclease Systems and Methods (US 11,963,982) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,938,521 | CRISPR/Cas-Related Methods and Compositions for Treating Leber's Congenital Amaurosis 10 (LCA10) In force · High confidence | In force | High confidence | |
| US 10,253,312 | CRISPR/Cas-Related Methods and Compositions for Treating Leber's Congenital Amaurosis 10 (LCA10) In force · High confidence | In force | High confidence | |
| US 11,141,493 | Compositions and methods for treating CEP290-associated disease In force · From the USPTO record | In force | From the USPTO record | |
| US 11,268,086 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER?S CONGENITAL AMAUROSIS 10 (LCA1p. In force · High confidence | In force | High confidence | |
| US 11,339,437 | Compositions and Methods for Treating CEP290-Associated Disease In force · High confidence | In force | High confidence | |
| US 11,566,263 | Compositions and Methods for Treating CEP290 Associated Disease In force · Medium confidence | In force | Medium confidence | |
| US 12,234,449 | CRISPR/Cas-Related Methods and Compositions for Treating Leber's Congenital Amaurosis 10 (LCA10) In force · Medium confidence | In force | Medium confidence | |
| US 12,460,231 | CRISPR/Cas-Related Methods and Compositions for Treating Primary Open Angle Glaucoma In force · High confidence | In force | High confidence | |
| US 11,680,268 | Methods for Improving CRISPR/Cas-Mediated Genome-Editing In force · High confidence | In force | High confidence | |
| US 12,201,699 | Compositions and Methods for Promoting Homology Directed Repair In force · High confidence | In force | High confidence |
Also on record, not counted in the 47: 7 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
34 pending · 32 abandoned · 6 no status recorded